Clinical Trials Directory

Trials / Completed

CompletedNCT03596242

SMS System for Patients With Uncontrolled Hypertension

Short Message Service System for Patients With Uncontrolled Hypertension

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Wake Forest University Health Sciences · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a pilot study to determine the potential of utilizing Short Message Service (SMS) messaging to improve health outcomes for patients with uncontrolled hypertension receiving care from the Outpatient Internal Medicine Clinic at Wake Forest Baptist Hospital.

Detailed description

The pilot will evaluate the feasibility of implementing a Short Message Service (SMS) system and Home Blood Pressure Measurements (HBPM) in the Outpatient Internal Medicine (OPD) clinic at Wake Forest Baptist Hospital. Implementing a new short text messaging service will improve the health delivery system in three ways. 1) Increasing patient engagement: SMS and HBPM require an active commitment by the patients themselves in their medical care and results in a marked improvement in the adherence to medication. High adherence to home blood pressure (BP) measurements has also been reported to improve BP control. 2) Supporting patients outside of the office visits by identifying and resolving barriers to medication adherence earlier on (i.e. if patients are unable to get their prescriptions or are having significant side effects). 3) Adopting clinical guidelines to improve BP control in a vulnerable population.

Conditions

Interventions

TypeNameDescription
OTHERSMS SystemParticipants will receive usual care +SMS texting and phone calls to monitor their blood pressure and medication adherence
BEHAVIORALblood pressure control educationstandard blood pressure control education given during visits

Timeline

Start date
2021-03-09
Primary completion
2021-12-06
Completion
2021-12-06
First posted
2018-07-23
Last updated
2023-09-28
Results posted
2023-09-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03596242. Inclusion in this directory is not an endorsement.